Global Central Nervous System Treatment Market To Be Driven By The Increasing Incidence Of Neurological Disorders In The Forecast Period Of 2023-2028

Central Nervous System Treatment Market

The new report by Expert Market Research titled, ‘Global Central Nervous System Treatment Market Share, Size, Growth, Analysis, Report and Forecast 2023-2028’, gives an in-depth analysis of the global central nervous system treatment market assessing the market based on its segments such as types, drug classes, drug types, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.

Get a Free Sample Report with Table of Contents:

The key highlights of the report include:

Market Overview (2018-2028)

• Forecast CAGR (2023-2028): 8.1%

There is a rapid increase in the prevalence and incidence of neurological disorders, such as multiple sclerosis, Alzheimer’s, and Parkinson’s, among others. The number of individuals with such disorders has increased over the last few years. This increase is set to positively influence the growth of the global central nervous system treatment market in the coming years. The increasing prevalence of neurological disorders and increasing diagnosis rates in developed and emerging countries are presenting a large patient pool undergoing treatment. This is further supported by the emphasis of non-profit organisations, healthcare systems, and market players on creating awareness regarding these conditions through campaigns, etcamong other factors. These factors, along with the introduction of the new generation of antipsychotic drugs by global and domestic players, are poised to drive the market’s growth opportunities.

Central Nervous System Treatment Industry Definition and Major Segments

The nervous system is divided into two parts: the central nervous system (CNS) (which includes the brain and spinal cord) and the peripheral nervous system (which includes the rest of the body) (consisting of nerves, including the autonomic nervous system, outside of the brain and spinal cord, including those in the arms, legs, and trunk of the body). Together, the brain and spinal cord serve as the principal “processing centre” for the entire nervous system, controlling all bodily activities.

Read Full Report with Table of Contents:

By type, the market is segmented into:

• Neurovascular Diseases
o Haemorrhagic Stroke
o Ischemic Stroke
o Others

• Neurodegenerative Diseases

o Alzheimer’s Disease
o Parkinson’s Disease
o Multiple Sclerosis
o Others

• Mental Health

o Epilepsy
o Mood Disorders
o Anxiety Disorders
o Others

• Infectious Diseases

o Meningitis
o Encephalitis
o Others

• Others

Based on drug class, the market is divided into:

• Immunomodulatory Drugs
• Interferons
• Decarboxylase Inhibitors
• Dopamine Agonists
• Antidepressants
• Analgesics
• Others

By drug type, the market is classified into:

• Biologics
• Non-Biologics

On the basis of region, the market is segmented into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Central Nervous System Treatment Market Trends

The global market is likely to be driven by the development of new treatment systems, regulations seeking to support treatment systems for central nervous system disorders, and technological innovations. Advances in the diagnosis and treatment of central nervous system (CNS) disorders are predicted to augment the global treatment rate. Due to the significant unmet medical need, all of the major pharmaceutical companies are investing in and developing innovative medicines for the treatment of CNS disorders. Further, the rising approval of generic products owing to patent expiration of key products, has led to an increase in treatment rates, especially in low- and middle-income countries. Regulatory guidelines and critical clinical trials are encouraging the entry of new products into the market for central nervous system treatment.

Key Market Players

The major players in the market are Teva Pharmaceutical Industries Ltd., Pfizer, Inc., F. Hoffmann-La Roche Ltd, Otsuka Pharmaceutical Co., Ltd., and Angelini S.p.a., among others.

The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

Read More Reports:

Overhead Cranes Market:

Corporate Wellness Market:

Protein Alternatives Market:

Muscle Stimulation Market:

Omega 3 Supplements Market:

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective, and intelligent business strategies and ensure their leadership in the market.

Media Contact:

Company Name: Claight Corporation
Contact Person: James Rowan, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA



Leave a Reply

Your email address will not be published. Required fields are marked *